{
  "id": "LSB10422",
  "type": "CRS Report Type LSB",
  "typeId": "LSB",
  "number": "LSB10422",
  "active": true,
  "source": "CRSReports.Congress.gov",
  "versions": [
    {
      "source_dir": "crsreports.congress.gov",
      "title": "COVID-19 Medical Countermeasures: Intellectual Property and Affordability",
      "retrieved": "2020-09-07T12:23:53.872813",
      "id": "LSB10422_1_2020-03-18",
      "formats": [
        {
          "filename": "files/2020-03-18_LSB10422_f09ef39b66fbf5e7d89cafee5095add79b4d1410.pdf",
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/LSB/LSB10422/1",
          "sha1": "f09ef39b66fbf5e7d89cafee5095add79b4d1410"
        },
        {
          "format": "HTML",
          "filename": "files/2020-03-18_LSB10422_f09ef39b66fbf5e7d89cafee5095add79b4d1410.html"
        }
      ],
      "date": "2020-03-18",
      "summary": null,
      "source": "CRSReports.Congress.gov",
      "typeId": "LSB",
      "active": true,
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=LSB10422",
      "type": "CRS Report Type LSB"
    }
  ],
  "topics": []
}